PATENT CLAIM ANALYSIS

Application Number: 16134144
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "053000"]

Abstract:
A method of treating or preventing type C Hepatic Encephalopathy in a human patient diagnosed with cirrhosis by administering a composition containing at least 200 mg biotin to the human patient daily.

Claim (Index 10):
The method of  claim 1 , wherein the composition is in the form of capsules, tablets, lozenges or pills.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15935695', '15352035', '15716838', '11720268', '13495966']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7163311989317175
- 35 USC 102 Novelty (BERT): 0.6244177257293794
- Combined Prediction Score: 0.7071398516114836
- Mean Citation Score: 327.511742
- Max Citation Score: 588.3417400000002
- Similarity Product: 494.7828260271074

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test